Related Experiment Video
Updated: Jan 6, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
Published on: November 8, 2024
Platelets Are at the Nexus of Vascular Diseases
Héloïse Lebas1, Katia Yahiaoui1, Raphaël Martos1
1Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Sorbonne Paris Cite, Univ Paris Diderot, Paris, France.
Insights
Platelets play a key role in cardiovascular diseases (CVD). Understanding platelet functions beyond clotting is crucial for developing safer treatments for vascular and thrombo-inflammatory diseases.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Immunology
Background:
- Platelets are critical in cardiovascular diseases (CVD).
- Current antiplatelet therapies face challenges with bleeding complications.
- Platelet interactions extend beyond hemostasis to inflammation and vascular injury.
Purpose of the Study:
- To provide a comprehensive overview of platelet mechanisms in vascular diseases.
- To explore the role of platelet functions in CVD progression.
- To identify new therapeutic strategies for thrombo-inflammatory diseases.
Main Methods:
- Literature review of recent studies on platelet function in vascular diseases.
- Analysis of platelet interactions with vascular cells and leukocytes.
- Synthesis of current knowledge on platelet mechanisms in thrombo-inflammation.
Main Results:
- Platelets are implicated in CVD progression through various mechanisms beyond aggregation.
- Platelet interactions with other cells contribute to vascular injury and inflammation.
- Existing antiplatelet drugs have limitations regarding bleeding risks.
Conclusions:
- A deeper understanding of platelet biology is essential for advancing CVD treatment.
- Targeting novel platelet pathways may offer safer therapeutic options.
- Further research into platelet mechanisms is needed for effective management of vascular and thrombo-inflammatory conditions.
Abstract:
Platelets are important actors of cardiovascular diseases (CVD). Current antiplatelet drugs that inhibit platelet aggregation have been shown to be effective in CVD treatment. However, the management of bleeding complications is still an issue in vascular diseases. While platelets can act individually, they interact with vascular cells and leukocytes at sites of vascular injury and inflammation. The main goal remains to better understand platelet mechanisms in thrombo-inflammatory diseases and provide new lines of safe treatments. Beyond their role in hemostasis and thrombosis, recent studies have reported the role of several aspects of platelet functions in CVD progression. In this review, we will provide a comprehensive overview of platelet mechanisms involved in several vascular diseases.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

